{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:59:21Z","timestamp":1790863161450,"version":"4.1.0"},"reference-count":75,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T00:00:00Z","timestamp":1706227200000},"content-version":"vor","delay-in-days":25,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HemaSphere"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Infection has emerged as the chief cause of non\u2010relapse mortality (NRM) post CD19\u2010targeting chimeric antigen receptor T\u2010cell therapy (CAR\u2010T) therapy. Even though up to 50% of patients may remain infection\u2010free, many suffer multiple severe, life\u2010threatening, or fatal infectious events. The primary aim of this study was to explore severe and life\u2010threatening infections post licensed CAR\u2010T therapy in large B\u2010cell lymphoma, with a focus on the role of disease burden and disease sites in assessing individual risk. We sought to understand the cohort of patients who experience \u22652 infections and those at the highest risk of infectious NRM. Our analysis identifies a higher disease burden after bridging therapy as associated with infection events. Those developing \u22652 infections emerged as a uniquely high\u2010risk cohort, particularly if the second (or beyond) infection occurred during an episode of immune effector cell\u2010associated neurotoxicity syndrome (ICANS) or while on steroids and\/or anakinra for ICANS. Herein, we also describe the first reported cases of \u201cCAR\u2010T cold sepsis,\u201d a phenomenon characterized by the lack of an appreciable systemic inflammatory response at the time of detection of infection. We propose a risk\u2010based strategy to encourage heightened clinician awareness of cold sepsis, with a view to reducing NRM.<\/jats:p>","DOI":"10.1002\/hem3.29","type":"journal-article","created":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T08:37:30Z","timestamp":1706258250000},"source":"Crossref","is-referenced-by-count":14,"title":["High pretreatment disease burden as a risk factor for infectious complications following CD19 chimeric antigen receptor T\u2010cell therapy for large B\u2010cell lymphoma"],"prefix":"10.1002","volume":"8","author":[{"given":"Maeve A.","family":"O'Reilly","sequence":"first","affiliation":[{"name":"Department of Haematology University College London Hospital London UK"},{"name":"University College London Cancer Institute London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna","family":"Neill","sequence":"additional","affiliation":[{"name":"Department of Haematology University College London Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon M.","family":"Collin","sequence":"additional","affiliation":[{"name":"Bristol Medical School University of Bristol Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Stone","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases University College London Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Springell","sequence":"additional","affiliation":[{"name":"Department of Haematology University College London Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Mensah","sequence":"additional","affiliation":[{"name":"Department of Haematology King's College London Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen P. L.","family":"Cheok","sequence":"additional","affiliation":[{"name":"Department of Haematology University College London Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Jalowiec","sequence":"additional","affiliation":[{"name":"Department of Haematology University College London Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuben","family":"Benjamin","sequence":"additional","affiliation":[{"name":"Department of Haematology King's College London Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4952-2550","authenticated-orcid":false,"given":"Andrea","family":"Kuhnl","sequence":"additional","affiliation":[{"name":"Department of Haematology King's College London Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Roddie","sequence":"additional","affiliation":[{"name":"Department of Haematology University College London Hospital London UK"},{"name":"University College London Cancer Institute London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Sanderson","sequence":"additional","affiliation":[{"name":"Department of Haematology King's College London Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,1,26]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804980"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31366-0"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004896"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy152"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-07-793760"},{"issue":"4","key":"e_1_2_9_8_1","first-page":"349","article-title":"GLA\/DRST real\u2010world outcome analysis of CAR\u2010T cell therapies for large B\u2010cell lymphoma in Germany","volume":"140","author":"Bethge WA","year":"2022","journal-title":"Blood"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004475"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.05.026"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010624"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.08.003"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022007474"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002732"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-00346-7"},{"key":"e_1_2_9_16_1","first-page":"ofaa121","volume-title":"Infectious Complications Following Cd19 Chimeric Antigen Receptor T\u2010cell Therapy for Children, Adolescents, and Young Adults","author":"Vora SB","year":"2020"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.845540"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020010543"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18209"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1086\/588660"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.09.013"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00374"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.12.003"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.758"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000535"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(21)00316-1"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.274"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.238634"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30376-8"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-022-01756-w"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13712"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31187-9"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00347-z"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)91980-3"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-04220-6_1"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(82)90082-4"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-04220-6_2"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1992.03480100060031"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/15.1.33"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-021-08870-5"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.12.676"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy1025"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl141"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2012.11.011"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02103"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002394"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.03585"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02104"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2019.10.006"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002311"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1136\/jim-2018-000893"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12873-019-0298-2"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1542\/hpeds.2020-002204"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000000987"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-016-1510-3"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000858"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5665"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0767-x"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00374"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023020578"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2009.02.002"},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e32834cf054"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02694"},{"key":"e_1_2_9_65_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004000"},{"key":"e_1_2_9_66_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-021-01526-0"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00741-2"},{"key":"e_1_2_9_68_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2023.2248329"},{"key":"e_1_2_9_69_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2022.2057487"},{"key":"e_1_2_9_70_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022009578"},{"key":"e_1_2_9_71_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016175"},{"key":"e_1_2_9_72_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.281719"},{"key":"e_1_2_9_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.09.007"},{"key":"e_1_2_9_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2022.04.012"},{"key":"e_1_2_9_75_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004575"},{"key":"e_1_2_9_76_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003885"}],"container-title":["HemaSphere"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hem3.29","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T12:41:40Z","timestamp":1736253700000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hem3.29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1002\/hem3.29"],"URL":"https:\/\/doi.org\/10.1002\/hem3.29","archive":["Portico"],"relation":{},"ISSN":["2572-9241","2572-9241"],"issn-type":[{"value":"2572-9241","type":"print"},{"value":"2572-9241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"article-number":"e29"}}